Finance Home
-
My Yahoo
-
Yahoo!
-
Help
Sunday, November 29, 2009, 1:51AM ET - U.S. Markets Closed.
Dow
1.48%
Nasdaq
1.73%
Home
Investing
Market Overview
Market Stats
Stocks
Mutual Funds
ETFs
Bonds
Options
Industries
Currencies
New!
Education
News & Opinion
Markets
Investing Ideas
Expert Advice
Special Editions
Company Finances
Providers
Personal Finance
Banking & Budgeting
Career & Work
College & Education
Family & Home
Insurance
Loans
Real Estate
Retirement
Taxes
How-to Guides
My Portfolios
Sign In to Create/Edit My Portfolios
Free trial of Real-Time Quotes
Tech Ticker
Get Quotes
Finance Search
Cypress Bioscience, Inc. (CYPB)
On
Nov 27
:
5.40
0.23
(4.09%)
MORE ON CYPB
Quotes
Summary
Real-Time
Options
Historical Prices
Charts
Interactive
Basic Chart
Basic Tech. Analysis
News & Info
Headlines
Financial Blogs
Company Events
Message Board
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Components
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Transactions
Insider Roster
Financials
Income Statement
Balance Sheet
Cash Flow
Research Reports
Get
Research Reports
for:
RECENT REPORTS
Released
Contributor
Author
Title
Pages
Price
29-Nov-2009
PriceTarget Research, Inc.
N/A
Cypress Bioscience has a current Overall Rating of D (Negative).
7
$25
28-Nov-2009
Standard & Poor's Quantitative Report
N/A
Cypress Bioscience
6
$25
27-Nov-2009
Pechala's Reports
Lubomir Pechala
CYPRESS BIOSCIENCE INC (CYPB=US) 2-weeks forecast
1
$10
27-Nov-2009
Pechala's Reports
Frantisek Pechala
CYPRESS BIOSCIENCE INC (CYPB=US) 12-months forecast
1
$15
26-Nov-2009
ValuEngine, Inc.
N/A
ValuEngine Industry Report for BIOTECHNOLOGY
18
$49
26-Nov-2009
Ford Investor Services, Inc.
N/A
Value Graph: CYPRESS BIOSCNCE -- CYPB
1
$4
26-Nov-2009
New Constructs, LLC
N/A
CYPB: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings
19
$10
26-Nov-2009
Pechala's Reports
Lubomir Pechala
CYPRESS BIOSCIENCE INC (CYPB=US) - REPORT FOR ACTIVE TRADERS
4
$25
24-Nov-2009
Jefferson Research
N/A
Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of CYPRESS BIOSCIENCE INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.
3
$20
23-Nov-2009
PriceTarget Research, Inc.
N/A
Biotechnology Intelligence Monitor: overall outlook STRONG - 25 new Leaders; 18 new Laggards.
58
$20
View All Reports for CYPB ...
Add to Portfolio
Set Alert
Email to a Friend
Get
Research Reports
for Another Symbol:
Symbol Lookup
Upgrades & Downgrades
Conference Calls